Financhill
Back

Phathom Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42

PHAT
Phathom Pharmaceuticals, Inc.

Last Price:
$16.98
Seasonality Move:
-12.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Phathom Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Phathom Pharmaceuticals, Inc. has on average historically risen by 15% based on the past 6 years of stock performance.
  • Phathom Pharmaceuticals, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Phathom Pharmaceuticals, Inc. Stock Undervalued?
    The current Phathom Pharmaceuticals, Inc. [PHAT] share price is $17.87. The Score for PHAT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • PHAT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Phathom Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Phathom Pharmaceuticals, Inc. has on average historically risen by 15% based on the past 6 years of stock performance.

Phathom Pharmaceuticals, Inc. Stock Rating

Sell
42
Phathom Pharmaceuticals, Inc. (PHAT) is a Sell

Is Phathom Pharmaceuticals, Inc. overpriced?

  • Phathom Pharmaceuticals, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Phathom Pharmaceuticals, Inc. Stock Price History

Is PHAT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
phathompharma.com

52-Week Data

52-Week High:
18.28
52-Week Low:
2.21

Prediction Charts

Market Cap:
1.3B
Price in USD:
17.87
Volume:
1.3M
Beta:
0.80

Technical Analysis

SMA50:
14.35
SMA100:
12.79
SMA200:
9.53
52-Wk Change:
139.87%

Stock Predictions

  • Is Phathom Pharmaceuticals, Inc. stock public?
    Yes, Phathom Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Phathom Pharmaceuticals, Inc. stock quote today?
    The Phathom Pharmaceuticals, Inc. stock price is 17.87 USD today.
  • How to buy Phathom Pharmaceuticals, Inc. stock online?
    You can buy Phathom Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 14.90 14.67 15.16 14.45
Dec-4 14.67 14.70 14.91 14.27
Dec-5 14.69 14.58 14.85 14.12
Dec-8 14.80 14.90 15.14 14.55
Dec-9 15.03 14.21 15.14 14.19
Dec-10 14.20 14.55 14.64 14.12
Dec-11 14.62 14.57 14.79 14.46
Dec-12 15.22 14.56 16.45 14.51
Dec-15 14.62 14.69 14.85 14.24
Dec-16 14.77 15.24 15.40 14.53
Dec-17 15.15 15.36 15.55 14.96
Dec-18 15.62 16.28 16.61 15.56
Dec-19 16.39 17.53 17.71 16.39
Dec-22 17.90 17.87 18.28 17.29

Phathom Pharmaceuticals, Inc. Earnings

Phathom Pharmaceuticals, Inc. Earnings Report: Per Share Phathom Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Phathom Pharmaceuticals, Inc. Forecast Revenue Growth

Phathom Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Phathom Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.36 per share, and an increase next year of $2.24 per share.

* Phathom Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.